FR
live
High CVSS 8.8

CVE-2026-66875

NVD analysis in progress

In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.

What this means

Exposure
Exploitable from the adjacent network, without authentication and with no action from the victim.
Impact
An attacker can read sensitive data, modify or destroy data and take the service offline.
Weakness
A sensitive function is reachable with no authentication at all.
Likelihood
Its EPSS score stays low: nothing points to imminent exploitation, which is no reason to leave it unpatched.

What to doFold into the next patch cycle.

Read automatically from the CVSS vector, the weakness type (CWE) and the EPSS score. The technical description above remains the one published by NIST.

Published
11 August 2026
CVSS
8.8 (v3.1) CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
EPSS
0.27% probability of exploitation within 30 days · above 19% of all CVEs
Weakness
CWE-306
Sources
nvd
References

Type at least two characters.

navigate open esc dismiss